• 
• Print
• Email
• Order a PDF

CAS Medical Systems Inc. lost money in the second quarter due to a sales decline and higher expenses that ate into the bottom line at the Branford maker of devices for monitoring patients' blood-oxygen levels.

CAS Med lost a net $1.4 million, or 11 cents a share, in the three months ended June 30 compared to an $8,000 net profit the same quarter last year.

Second-quarter revenues fell to $5.7 million from $6.3 million a year ago.

CEO Thomas Patton said discontinued products, plus a drop in overseas sales of vital signs monitors contributed to CAS Med's reduced financial performance.

• 
• Print
• Email
• Order a PDF